• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Amgen

Amgen

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Amgen Joins With LabCentral To Support Life-Sciences And Biotech Startups In Cambridge, Massachusetts

    Amgen Joins With LabCentral To Support Life-Sciences And Biotech Startups In Cambridge, Massachusetts

  2. Amgen Announces 30 Percent Increase In 2015 First Quarter Dividend

    Amgen Announces 30 Percent Increase In 2015 First Quarter Dividend

  3. Amgen Presents Data From Pivotal Phase 2 Study Of BLINCYTO™ (blinatumomab) Immunotherapy In Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia

    Amgen Presents Data From Pivotal Phase 2 Study Of BLINCYTO™ (blinatumomab) Immunotherapy In Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia

  4. Amgen Announces New Data From Phase 2 BLINCYTO™ (blinatumomab) Immunotherapy Study In Patients With Acute Lymphoblastic Leukemia And Minimal Residual Disease

    Amgen Announces New Data From Phase 2 BLINCYTO™ (blinatumomab) Immunotherapy Study In Patients With Acute Lymphoblastic Leukemia And Minimal Residual Disease

  5. Ligand Partner Spectrum Pharmaceuticals Announces Submission of New Drug Application for Captisol-Enabled™ Melphalan

    Ligand Partner Spectrum Pharmaceuticals Announces Submission of New Drug Application for Captisol-Enabled™ Melphalan

  6. UPDATE: Cal-Maine Foods shares fall on earnings miss

    UPDATE: Cal-Maine Foods shares fall on earnings miss

  7. Amgen To Webcast Investor Meeting At Upcoming American Society of Hematology (ASH) 56th Annual Meeting And Exposition

    Amgen To Webcast Investor Meeting At Upcoming American Society of Hematology (ASH) 56th Annual Meeting And Exposition

  8. Ultimate Stock-Pickers: Top Holdings of Top-Performing Managers

    Our Ultimate Stock-Pickers Index continues to beat the market even as relatively few of our top managers are outperforming the S&P 500.

  9. Research and Markets: Post Menopausal Osteoporosis - Pipeline Review, H1 2014

    Research and Markets: Post Menopausal Osteoporosis - Pipeline Review, H1 2014

  10. ImmunoGen Reports Roche Has Provided an Update on the MARIANNE Trial

    ImmunoGen Reports Roche Has Provided an Update on the MARIANNE Trial

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.